Cite

HARVARD Citation

    Rao, I. et al. (2017). Rituximab is effective as first line therapy in the management of steroid sensitive, but dependent/relapsing adult Nephrotic syndrome. Nephrology. 22 (9), pp. 731-732. [Online]. 
  
Back to record